Gelomuloside B is primarily investigated for its potential bioactive properties, particularly in the field of pharmaceutical research. It has shown promising antimicrobial and anti-inflammatory activities in preliminary studies, making it a candidate for development in therapeutic agents. Its structure suggests possible interactions with cellular pathways involved in immune response modulation, which could be leveraged in treating chronic inflammatory conditions. Additionally, due to its natural origin and unique glycosidic framework, it serves as a lead compound for synthesizing derivatives with enhanced biological activity. Research is ongoing to explore its efficacy and safety for potential use in medicine.